Our p53 phosphorylation studies revealed an induced p53 phosphorylation at Ser15 in the cisplatin-treated CRL5985, suggesting a role of p53 activation in the cisplatin-induced PUMA expression of CRL5985 lung cancer cells (Figure 4). Here, TP53 is linked to lung carcinoma.